United Kingdom Ferritin Testing Market Size, Share, and COVID-19 Impact Analysis, By Product (Instrument, Reagent, and Kits), By Application (Anemia, Hemochromatosis, Lead Poisoning, Pregnancy, and Others), and United Kingdom Ferritin Testing Market Insights, Industry Trend, Forecasts to 2035

United Kingdom Ferritin Testing Market Insights Forecasts to 2035

• The United Kingdom Ferritin Testing Market Size was estimated at USD 28.89 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 7.92% from 2025 to 2035
• The United Kingdom Ferritin Testing Market Size is Expected to Reach USD 66.79 Million by 2035

According to a research report published by Spherical Insights & Consulting, the United Kingdom Ferritin Testing Market is anticipated to reach USD 66.79 million by 2035, growing at a CAGR of 7.92% from 2025 to 2035. The need for ferritin testing services has increased at an unprecedented rate in recent years due to government measures to reduce anaemia and other blood-related diseases, which has increased ferritin testing service sales.

Market Overview

The United Kingdom ferritin testing market refers to the subsegment of the healthcare focused on diagnostic tools and services used to measure ferritin levels, a key protein that stores iron in the body and reflects iron status. A key measure of the body's iron reserves, ferritin levels are used to diagnose and track a number of disorders associated with iron overload or shortage, including hemochromatosis, chronic illnesses, and iron deficiency anemia. While high ferritin levels may indicate iron overload or illnesses like liver disease, inflammation, or chronic illness, low ferritin levels frequently indicate iron insufficiency. The results of the test, which is usually conducted using blood samples, assist medical professionals in determining the body's iron status, directing treatment regimens, and monitoring the course of disease. Further, iron deficiency anemia is becoming more common, especially in women, children, and the elderly, which highlights the market growth opportunities. Moreover, the market opportunities are boosted by an increase in iron deficiency anemia cases and associated conditions, including cancer and chronic kidney disease. The aging of the population and growing knowledge of the significance of monitoring iron levels which boosting the market. The National Health Service (NHS), for instance, has been working to improve the identification of anemia using blood tests, such as ferritin levels, as part of standard health screenings. Additionally, businesses like Abbott and Roche provide sophisticated diagnostic solutions, such as automated ferritin testing equipment, to improve precision and cut down on testing time in medical institutions.

Report Coverage

This research report categorizes the market for the United Kingdom ferritin testing market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom ferritin testing market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United Kingdom ferritin testing market.

Driving Factors

The market for United Kingdom ferritin testing is influenced by the increased incidence of iron excess diseases, including hemochromatosis and iron-deficient anemia. The need for iron monitoring has increased as a result of growing understanding of its significance for chronic illnesses, pediatric populations, and maternal health. Technological developments in diagnostics, such as automated analyzers and point-of-care testing kits, have improved accessibility and precision, which has fueled market expansion even more. Additionally, the use of ferritin tests for early diagnosis and efficient treatment management is supported by the increased emphasis on preventive healthcare as well as the developing healthcare infrastructure in emerging markets. The market also gains from government programs that support early disease identification and the increasing use of automated testing and point-of-care systems, which increase accessibility and efficiency in healthcare environments.

Restraining Factors

Despite the significant growth, the market could be slowed due to a lack of public awareness, high cost, and accessibility issues can also arise, technically speaking, test accuracy variation, and regulatory obstacles.

Market Segmentation

The United Kingdom ferritin testing market share is classified into product, and application.

• The kits segment held a significant share in 2024 and is expected to grow at a rapid pace during the forecast period.

The United Kingdom ferritin testing market is segmented by product into instrument, reagent, and kits. Among these, the kits segment held a significant share in 2024 and is expected to grow at a rapid pace during the forecast period. The widespread usage of the growing need for readily usable diagnostic solutions is driving the fastest growth rate in the kits segment. Further, their simplicity of use and compatibility with automated systems, ELISA, and chemiluminescent test kits are becoming more and more popular. The growth of this market is driven by the increasing importance of quick and precise ferritin assessment for the treatment of anemia.

• The anemia segment dominated the market in 2024 and is anticipated to grow at a significant CAGR over the forecast period.

The United Kingdom ferritin testing market is segmented by application into anemia, hemochromatosis, lead poisoning, pregnancy, and others. Among these, the anemia segment dominated the market in 2024 and is anticipated to grow at a significant CAGR over the forecast period. This is because of the growing need for anemia diagnosis and treatment. Additionally, this rise is anticipated to be further accelerated by the segment rapid expansion, notably in point-of-care and home-testing equipment.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom ferritin testing market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• MedTech Services Laboratory
• Mayfield Clinic
• Phoenix Pathology
• Welzo
• Thriva
• HCA Healthcare
• Others

Recent Developments:

• In November 2022, 2San, a global healthcare innovator, launched a comprehensive range of self-diagnostic tests in the UK, aiming to empower individuals to take control of their health from home. 2San has teamed up with major UK pharmacies like LloydsPharmacy, Pharmacy2U, and Phoenix Healthcare, making these tests widely available online and in over 5,500 pharmacy locations.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at United Kingdom, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom ferritin testing market based on the below-mentioned segments:

United Kingdom Ferritin Testing Market, By Product

• Instrument
• Reagent
• Kits

United Kingdom Ferritin Testing Market, By Application

• Anemia
• Hemochromatosis
• Lead Poisoning
• Pregnancy
• Others